Poland implemented its medical cannabis program in 2017, with legal sales eventually being permitted through the nation’s registered pharmacies. According to initial reporting by Leafly in 2017, “nearly 90% will be authorized to distribute cannabis, and the Polish Pharmaceutical Chamber anticipates that up to 300,000 patients could qualify for medical marijuana treatment.”
While the 300,000 high-end estimate has yet to materialize, Poland did see doctors issue 27,687 medical cannabis prescriptions in 2023. That figure is up from 2,909 prescriptions issued in 2019. An estimated 33.2kg of medical cannabis was dispensed in 2019 in Poland compared to 4.6t in 2023.
Statista lists the following for Poland’s emerging legal medical cannabis industry:
- Poland is expected to reach a revenue of US$134.80m in the Cannabis market by 2024.
- The revenue is forecasted to grow annually at a rate of 3.56% (CAGR 2024-2029), leading to a market volume of US$160.60m by 2029.
A February 2024 poll conducted in Poland by the Polish Centre for Investigating Public Opinions found that 73.4% of participants support decriminalizing cannabis for adults in the European country.
According to a recent market analysis by Research and Markets, the emerging legal European medical cannabis industry is set to undergo considerable growth between now and 2028.
“The burgeoning Europe medical marijuana market is poised for robust growth, as evidenced by the latest market insights which project an impressive leap from US$ 3,414.26 million in 2022 to US$ 9,703.38 million by 2028.” the researchers stated in a press release.
The global legal medical cannabis market is projected to reach $82.5 billion by 2030 according to a separate report by Research and Markets. The legal medical cannabis market was worth an estimated $32.3 billion in 2023 according to the report.
“Extract Form Marijuana, one of the segments analyzed in the report, is expected to record 14.6% CAGR and reach US$54.2 Billion by the end of the analysis period. Growth in the Dried Flower Marijuana segment is estimated at 13.7% CAGR for the next 7-year period.” Research and Markets stated in a press release.
The global cannabidiol (CBD) market was worth an estimated $7.6 billion in 2023 according to a previous market analysis by Market.us, and will climb to a projected $36.6 in value by 2033.
“Between 2023 and 2032, this market is estimated to register the highest CAGR of 27%.” the researchers stated.
The global cannabis edibles market is projected to reach $27.2 billion by 2030 according to a previous market analysis by Fairfield Market Research. For comparison purposes, the same researchers estimated that the global cannabis edibles market was worth $9.6 billion in 2022.
“This robust growth will be driven by a multitude of factors, including shifting consumer preferences away from smoking cannabis, and rising awareness of the health benefits associated with cannabis edibles.” Fairfield Market Research stated in a press release.